Report Detail
COVID-19 Impact on Global OTC Drug, Market Insights and Forecast to 2026
- RnM4074502 |
- 23 June, 2020 |
- Global |
- 147 Pages |
- QYResearch |
- Pharma & Healthcare
OTC Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the OTC Drug market is segmented into
Class A
Class B
Segment by Application, the OTC Drug market is segmented into
Hospital
Clinic
Household
Regional and Country-level Analysis
The OTC Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the OTC Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and OTC Drug Market Share Analysis
OTC Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in OTC Drug business, the date to enter into the OTC Drug market, OTC Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
1 Study Coverage
- 1.1 OTC Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key OTC Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global OTC Drug Market Size Growth Rate by Type
- 1.4.2 Class A
- 1.4.3 Class B
- 1.5 Market by Application
- 1.5.1 Global OTC Drug Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Household
- 1.6 Coronavirus Disease 2019 (Covid-19): OTC Drug Industry Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Drug Industry
- 1.6.1.1 OTC Drug Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and OTC Drug Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for OTC Drug Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the OTC Drug Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global OTC Drug Market Size Estimates and Forecasts
- 2.1.1 Global OTC Drug Revenue 2015-2026
- 2.1.2 Global OTC Drug Sales 2015-2026
- 2.2 OTC Drug Market Size by Region: 2020 Versus 2026
- 2.2.1 Global OTC Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global OTC Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global OTC Drug Competitor Landscape by Players
- 3.1 OTC Drug Sales by Manufacturers
- 3.1.1 OTC Drug Sales by Manufacturers (2015-2020)
- 3.1.2 OTC Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 OTC Drug Revenue by Manufacturers
- 3.2.1 OTC Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 OTC Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global OTC Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2019
- 3.2.5 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 OTC Drug Price by Manufacturers
- 3.4 OTC Drug Manufacturing Base Distribution, Product Types
- 3.4.1 OTC Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers OTC Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into OTC Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global OTC Drug Market Size by Type (2015-2020)
- 4.1.1 Global OTC Drug Sales by Type (2015-2020)
- 4.1.2 Global OTC Drug Revenue by Type (2015-2020)
- 4.1.3 OTC Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global OTC Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global OTC Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global OTC Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 OTC Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global OTC Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global OTC Drug Market Size by Application (2015-2020)
- 5.1.1 Global OTC Drug Sales by Application (2015-2020)
- 5.1.2 Global OTC Drug Revenue by Application (2015-2020)
- 5.1.3 OTC Drug Price by Application (2015-2020)
- 5.2 OTC Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global OTC Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global OTC Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global OTC Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America OTC Drug by Country
- 6.1.1 North America OTC Drug Sales by Country
- 6.1.2 North America OTC Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America OTC Drug Market Facts & Figures by Type
- 6.3 North America OTC Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe OTC Drug by Country
- 7.1.1 Europe OTC Drug Sales by Country
- 7.1.2 Europe OTC Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe OTC Drug Market Facts & Figures by Type
- 7.3 Europe OTC Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific OTC Drug by Region
- 8.1.1 Asia Pacific OTC Drug Sales by Region
- 8.1.2 Asia Pacific OTC Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific OTC Drug Market Facts & Figures by Type
- 8.3 Asia Pacific OTC Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America OTC Drug by Country
- 9.1.1 Latin America OTC Drug Sales by Country
- 9.1.2 Latin America OTC Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America OTC Drug Market Facts & Figures by Type
- 9.3 Central & South America OTC Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa OTC Drug by Country
- 10.1.1 Middle East and Africa OTC Drug Sales by Country
- 10.1.2 Middle East and Africa OTC Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa OTC Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa OTC Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bayer HealthCare
- 11.1.1 Bayer HealthCare Corporation Information
- 11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
- 11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer HealthCare OTC Drug Products Offered
- 11.1.5 Bayer HealthCare Recent Development
- 11.2 GlaxoSmithKline (GSK)
- 11.2.1 GlaxoSmithKline (GSK) Corporation Information
- 11.2.2 GlaxoSmithKline (GSK) Description, Business Overview and Total Revenue
- 11.2.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 GlaxoSmithKline (GSK) OTC Drug Products Offered
- 11.2.5 GlaxoSmithKline (GSK) Recent Development
- 11.3 Johnson&Johnson
- 11.3.1 Johnson&Johnson Corporation Information
- 11.3.2 Johnson&Johnson Description, Business Overview and Total Revenue
- 11.3.3 Johnson&Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Johnson&Johnson OTC Drug Products Offered
- 11.3.5 Johnson&Johnson Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Corporation Information
- 11.4.2 Pfizer Description, Business Overview and Total Revenue
- 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Pfizer OTC Drug Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Sanofi
- 11.5.1 Sanofi Corporation Information
- 11.5.2 Sanofi Description, Business Overview and Total Revenue
- 11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sanofi OTC Drug Products Offered
- 11.5.5 Sanofi Recent Development
- 11.6 AstraZeneca
- 11.6.1 AstraZeneca Corporation Information
- 11.6.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 AstraZeneca OTC Drug Products Offered
- 11.6.5 AstraZeneca Recent Development
- 11.7 BioGaia
- 11.7.1 BioGaia Corporation Information
- 11.7.2 BioGaia Description, Business Overview and Total Revenue
- 11.7.3 BioGaia Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 BioGaia OTC Drug Products Offered
- 11.7.5 BioGaia Recent Development
- 11.8 Bristol Myers Squibb
- 11.8.1 Bristol Myers Squibb Corporation Information
- 11.8.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
- 11.8.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bristol Myers Squibb OTC Drug Products Offered
- 11.8.5 Bristol Myers Squibb Recent Development
- 11.9 Bukwang Pharmaceutica
- 11.9.1 Bukwang Pharmaceutica Corporation Information
- 11.9.2 Bukwang Pharmaceutica Description, Business Overview and Total Revenue
- 11.9.3 Bukwang Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Bukwang Pharmaceutica OTC Drug Products Offered
- 11.9.5 Bukwang Pharmaceutica Recent Development
- 11.10 Chr. Hansen
- 11.10.1 Chr. Hansen Corporation Information
- 11.10.2 Chr. Hansen Description, Business Overview and Total Revenue
- 11.10.3 Chr. Hansen Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Chr. Hansen OTC Drug Products Offered
- 11.10.5 Chr. Hansen Recent Development
- 11.1 Bayer HealthCare
- 11.1.1 Bayer HealthCare Corporation Information
- 11.1.2 Bayer HealthCare Description, Business Overview and Total Revenue
- 11.1.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer HealthCare OTC Drug Products Offered
- 11.1.5 Bayer HealthCare Recent Development
- 11.12 CoLucid
- 11.12.1 CoLucid Corporation Information
- 11.12.2 CoLucid Description, Business Overview and Total Revenue
- 11.12.3 CoLucid Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 CoLucid Products Offered
- 11.12.5 CoLucid Recent Development
- 11.13 Daiichi Sankyo
- 11.13.1 Daiichi Sankyo Corporation Information
- 11.13.2 Daiichi Sankyo Description, Business Overview and Total Revenue
- 11.13.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Daiichi Sankyo Products Offered
- 11.13.5 Daiichi Sankyo Recent Development
- 11.14 Friggs
- 11.14.1 Friggs Corporation Information
- 11.14.2 Friggs Description, Business Overview and Total Revenue
- 11.14.3 Friggs Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Friggs Products Offered
- 11.14.5 Friggs Recent Development
- 11.15 DSM
- 11.15.1 DSM Corporation Information
- 11.15.2 DSM Description, Business Overview and Total Revenue
- 11.15.3 DSM Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 DSM Products Offered
- 11.15.5 DSM Recent Development
- 11.16 Eisai
- 11.16.1 Eisai Corporation Information
- 11.16.2 Eisai Description, Business Overview and Total Revenue
- 11.16.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Eisai Products Offered
- 11.16.5 Eisai Recent Development
- 11.17 Eli Lilly
- 11.17.1 Eli Lilly Corporation Information
- 11.17.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.17.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Eli Lilly Products Offered
- 11.17.5 Eli Lilly Recent Development
- 11.18 Herbalife
- 11.18.1 Herbalife Corporation Information
- 11.18.2 Herbalife Description, Business Overview and Total Revenue
- 11.18.3 Herbalife Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Herbalife Products Offered
- 11.18.5 Herbalife Recent Development
- 11.19 Euradite
- 11.19.1 Euradite Corporation Information
- 11.19.2 Euradite Description, Business Overview and Total Revenue
- 11.19.3 Euradite Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Euradite Products Offered
- 11.19.5 Euradite Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 OTC Drug Market Estimates and Projections by Region
- 12.1.1 Global OTC Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global OTC Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America OTC Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: OTC Drug Sales Forecast (2021-2026)
- 12.2.2 North America: OTC Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: OTC Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe OTC Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: OTC Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: OTC Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: OTC Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific OTC Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: OTC Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: OTC Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: OTC Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America OTC Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: OTC Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: OTC Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: OTC Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa OTC Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: OTC Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: OTC Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: OTC Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key OTC Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 OTC Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global OTC Drug. Industry analysis & Market Report on COVID-19 Impact on Global OTC Drug is a syndicated market report, published as COVID-19 Impact on Global OTC Drug, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global OTC Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
